- Home
- DRUG vs INBK Comparison
DRUG vs INBK Comparison
Compare DRUG & INBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- INBK
- Stock Information
- Founded
- DRUG 2019
- INBK 1999
- Country
- DRUG United States
- INBK United States
- Employees
- DRUG N/A
- INBK N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- INBK Major Banks
- Sector
- DRUG Health Care
- INBK Finance
- Exchange
- DRUG Nasdaq
- INBK Nasdaq
- Market Cap
- DRUG 199.7M
- INBK 196.2M
- IPO Year
- DRUG N/A
- INBK N/A
- Fundamental
- Price
- DRUG $33.63
- INBK $21.46
- Analyst Decision
- DRUG Strong Buy
- INBK Hold
- Analyst Count
- DRUG 7
- INBK 3
- Target Price
- DRUG $83.25
- INBK $30.67
- AVG Volume (30 Days)
- DRUG 37.4K
- INBK 67.5K
- Earning Date
- DRUG 08-13-2025
- INBK 07-23-2025
- Dividend Yield
- DRUG N/A
- INBK 1.09%
- EPS Growth
- DRUG N/A
- INBK N/A
- EPS
- DRUG N/A
- INBK 1.76
- Revenue
- DRUG N/A
- INBK $106,219,000.00
- Revenue This Year
- DRUG N/A
- INBK $6.41
- Revenue Next Year
- DRUG N/A
- INBK $17.52
- P/E Ratio
- DRUG N/A
- INBK $12.47
- Revenue Growth
- DRUG N/A
- INBK 4.74
- 52 Week Low
- DRUG $0.94
- INBK $19.54
- 52 Week High
- DRUG $79.02
- INBK $43.27
- Technical
- Relative Strength Index (RSI)
- DRUG 64.40
- INBK 24.95
- Support Level
- DRUG $31.80
- INBK $22.84
- Resistance Level
- DRUG $36.50
- INBK $24.04
- Average True Range (ATR)
- DRUG 2.44
- INBK 1.15
- MACD
- DRUG 0.79
- INBK -0.72
- Stochastic Oscillator
- DRUG 70.86
- INBK 4.84
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.